Prophylactic and risk-reducing bilateral salpingo-oophorectomy: Recommendations based on risk of ovarian cancer

Jonathan S. Berek, Eva Chalas, Mitchell Edelson, David H. Moore, William M. Burke, William Arthur Cliby, Andrew Berchuck

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Women who do not have a documented germline mutation or who do not have a strong family history suspicious for a germline mutation are considered to be at average risk of ovarian cancer. Women who have confirmed deleterious BRCA1 and BRCA2 germline mutations are high risk of ovarian cancer. In addition, women who have a strong family history of either ovarian or breast cancer may carry a deleterious mutation and must be presumed to be at higher-than-average risk, even if they have not been tested, because there could be other mutations that are either untested or yet undiscovered that confirm higher-than-average risk of these diseases. We reviewed studies pertaining to prophylactic bilateral salpingo-oophorectomy in women at average risk of ovarian cancer who are undergoing hysterectomy for benign disease. We also reviewed the role of prophylactic bilateral salpingo-oophorectomy in preventing ovarian cancer based on the level of risk of the patient. For women at average risk of ovarian cancer who are undergoing a hysterectomy for benign conditions, the decision to perform prophylactic bilateral salpingo-oophorectomy should be individualized after appropriate informed consent, including a careful analysis of personal risk factors. Several studies suggest an overall negative health effect when prophylactic bilateral salpingo-oophorectomy is performed before the age of menopause. Ovarian conservation before menopause may be especially important in patients with a personal or strong family history of cardiovascular or neurological disease. Conversely, women at high risk of ovarian cancer should undergo risk-reducing bilateral salpingo-oophorectomy.

Original languageEnglish (US)
Pages (from-to)733-743
Number of pages11
JournalObstetrics and Gynecology
Volume116
Issue number3
DOIs
StatePublished - Sep 2010

Fingerprint

Ovariectomy
Ovarian Neoplasms
Germ-Line Mutation
Menopause
Hysterectomy
Mutation
Informed Consent
Breast Neoplasms
Health

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Prophylactic and risk-reducing bilateral salpingo-oophorectomy : Recommendations based on risk of ovarian cancer. / Berek, Jonathan S.; Chalas, Eva; Edelson, Mitchell; Moore, David H.; Burke, William M.; Cliby, William Arthur; Berchuck, Andrew.

In: Obstetrics and Gynecology, Vol. 116, No. 3, 09.2010, p. 733-743.

Research output: Contribution to journalArticle

Berek, Jonathan S. ; Chalas, Eva ; Edelson, Mitchell ; Moore, David H. ; Burke, William M. ; Cliby, William Arthur ; Berchuck, Andrew. / Prophylactic and risk-reducing bilateral salpingo-oophorectomy : Recommendations based on risk of ovarian cancer. In: Obstetrics and Gynecology. 2010 ; Vol. 116, No. 3. pp. 733-743.
@article{348e0530393a48438fde7658fcdddaa5,
title = "Prophylactic and risk-reducing bilateral salpingo-oophorectomy: Recommendations based on risk of ovarian cancer",
abstract = "Women who do not have a documented germline mutation or who do not have a strong family history suspicious for a germline mutation are considered to be at average risk of ovarian cancer. Women who have confirmed deleterious BRCA1 and BRCA2 germline mutations are high risk of ovarian cancer. In addition, women who have a strong family history of either ovarian or breast cancer may carry a deleterious mutation and must be presumed to be at higher-than-average risk, even if they have not been tested, because there could be other mutations that are either untested or yet undiscovered that confirm higher-than-average risk of these diseases. We reviewed studies pertaining to prophylactic bilateral salpingo-oophorectomy in women at average risk of ovarian cancer who are undergoing hysterectomy for benign disease. We also reviewed the role of prophylactic bilateral salpingo-oophorectomy in preventing ovarian cancer based on the level of risk of the patient. For women at average risk of ovarian cancer who are undergoing a hysterectomy for benign conditions, the decision to perform prophylactic bilateral salpingo-oophorectomy should be individualized after appropriate informed consent, including a careful analysis of personal risk factors. Several studies suggest an overall negative health effect when prophylactic bilateral salpingo-oophorectomy is performed before the age of menopause. Ovarian conservation before menopause may be especially important in patients with a personal or strong family history of cardiovascular or neurological disease. Conversely, women at high risk of ovarian cancer should undergo risk-reducing bilateral salpingo-oophorectomy.",
author = "Berek, {Jonathan S.} and Eva Chalas and Mitchell Edelson and Moore, {David H.} and Burke, {William M.} and Cliby, {William Arthur} and Andrew Berchuck",
year = "2010",
month = "9",
doi = "10.1097/AOG.0b013e3181ec5fc1",
language = "English (US)",
volume = "116",
pages = "733--743",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Prophylactic and risk-reducing bilateral salpingo-oophorectomy

T2 - Recommendations based on risk of ovarian cancer

AU - Berek, Jonathan S.

AU - Chalas, Eva

AU - Edelson, Mitchell

AU - Moore, David H.

AU - Burke, William M.

AU - Cliby, William Arthur

AU - Berchuck, Andrew

PY - 2010/9

Y1 - 2010/9

N2 - Women who do not have a documented germline mutation or who do not have a strong family history suspicious for a germline mutation are considered to be at average risk of ovarian cancer. Women who have confirmed deleterious BRCA1 and BRCA2 germline mutations are high risk of ovarian cancer. In addition, women who have a strong family history of either ovarian or breast cancer may carry a deleterious mutation and must be presumed to be at higher-than-average risk, even if they have not been tested, because there could be other mutations that are either untested or yet undiscovered that confirm higher-than-average risk of these diseases. We reviewed studies pertaining to prophylactic bilateral salpingo-oophorectomy in women at average risk of ovarian cancer who are undergoing hysterectomy for benign disease. We also reviewed the role of prophylactic bilateral salpingo-oophorectomy in preventing ovarian cancer based on the level of risk of the patient. For women at average risk of ovarian cancer who are undergoing a hysterectomy for benign conditions, the decision to perform prophylactic bilateral salpingo-oophorectomy should be individualized after appropriate informed consent, including a careful analysis of personal risk factors. Several studies suggest an overall negative health effect when prophylactic bilateral salpingo-oophorectomy is performed before the age of menopause. Ovarian conservation before menopause may be especially important in patients with a personal or strong family history of cardiovascular or neurological disease. Conversely, women at high risk of ovarian cancer should undergo risk-reducing bilateral salpingo-oophorectomy.

AB - Women who do not have a documented germline mutation or who do not have a strong family history suspicious for a germline mutation are considered to be at average risk of ovarian cancer. Women who have confirmed deleterious BRCA1 and BRCA2 germline mutations are high risk of ovarian cancer. In addition, women who have a strong family history of either ovarian or breast cancer may carry a deleterious mutation and must be presumed to be at higher-than-average risk, even if they have not been tested, because there could be other mutations that are either untested or yet undiscovered that confirm higher-than-average risk of these diseases. We reviewed studies pertaining to prophylactic bilateral salpingo-oophorectomy in women at average risk of ovarian cancer who are undergoing hysterectomy for benign disease. We also reviewed the role of prophylactic bilateral salpingo-oophorectomy in preventing ovarian cancer based on the level of risk of the patient. For women at average risk of ovarian cancer who are undergoing a hysterectomy for benign conditions, the decision to perform prophylactic bilateral salpingo-oophorectomy should be individualized after appropriate informed consent, including a careful analysis of personal risk factors. Several studies suggest an overall negative health effect when prophylactic bilateral salpingo-oophorectomy is performed before the age of menopause. Ovarian conservation before menopause may be especially important in patients with a personal or strong family history of cardiovascular or neurological disease. Conversely, women at high risk of ovarian cancer should undergo risk-reducing bilateral salpingo-oophorectomy.

UR - http://www.scopus.com/inward/record.url?scp=77957285812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957285812&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e3181ec5fc1

DO - 10.1097/AOG.0b013e3181ec5fc1

M3 - Article

C2 - 20733460

AN - SCOPUS:77957285812

VL - 116

SP - 733

EP - 743

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -